OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
April 28, 2015
Mylan announces a recall of eight lots of injectable products due to visible foreign particulate matter.
FDA releases long-awaited guidance documents regarding the assessment of biosimilarity.
April 27, 2015
Catalent’s Zydis technology will be used to develop thermo-stable and cold-chain independent vaccines.
April 24, 2015
The agency has recommended granting marketing authorization for Opdivo.
Dicerna Pharmaceuticals announces that FDA granted its primary hyperoxaluria type 1 (PH1) treatment Orphan Drug designation.
April 23, 2015
Originator product manufacturers will have to update and improve their processing platforms to stay competitive with the biosimilars coming to market.
April 21, 2015
A presentation by Jim Miller will offer a detailed review of the contract services landscape.
April 20, 2015
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
April 17, 2015
PTI's next-generation VeriPac Inspection System, the VeriPac 310, uses new vacuum-decay technology to increase leak-detection accuracy for a range of flexible and rigid packages and containers.
The acquisition expands Sartorius Stedim Biotech’s service portfolio.